In these two articles, Ms. Myers comments on FDA Commissioner Hamburg’s appointment of Stephen Spielberg to fill the new role of Deputy Commissioner for Medical Products and Tobacco. “The reorganization is an effort to try to find a way of getting [the centers] on same page,” Ms. Myers states. “A number of products will be crossing CDRH, CBER, CDER worlds and you need to create common polices between them.”
However, she also cautions that the addition of this new layer of management has the potential to slow timely access between center directors and Hamburg on urgent issues.
“Hamburg Creates New Positions to Oversee Medical Products, Global Regulation”
“New FDA Deputy Commissioner: Personalized Medicine, Pediatrics Likely to Be Major Areas of Focus”
Drug Industry Daily